In a filing earlier this week, a Chinese biotech company laid out its case for asking a court to enjoin a Trump administration decision to designate it as a "Chinese Military Company."

EU and Chinese trade officials met on Monday, and settled on a roadmap for future talks that seeks to produce "tangible results" by October. Separately, the EU is now moving ahead with new tariffs to protect its steel industry from global overcapacity, a move which has already been

New legislation introduced in both the U.S. House and Senate would establish an oversight body to scrutinize any Chinese investment made pursuant to a proposed U.S.-China Board of Investment.

Chinese-linked automaker Polestar has announced that it was not granted authorization by the U.S. Department of Commerce to sell "connected vehicles" in the United States, and therefore would be leaving the U.S. market as of the 2027 model year.

At a European Parliament meeting last week, a European Commission official provided an update on the status of the first case under the EU's International Procurement Instrument (IPI), which addressed barriers in the Chinese medical devices market.

This past week, CTM covered the following issues. China launched a two-front regulatory offensive against the U.S. defense sector, placing 10 American entities on an export control blacklist while barring 46 U.S. firms from participating in domestic government procurement. The move represents countermeasures in response to the

Canada has imposed provisional tariffs on imports of canned vegetables, with a determination on final tariffs for these products scheduled for September.